Tomas Kahn - Concepedia

Author

Tomas Kahn

German Cancer Research Center

Also Known As

T Kahn, T. Kahn, T.Z. Kahn, TOMAS KAHN, Thomas Kahn, Tomas Kahn

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

German Cancer Research Center DKFZ-ZMBH Alliance Christian-Albrechts-Universität zu Kiel Heidelberg University Deutsche Bank (Germany)

About

Tomas Kahn is an author at German Cancer Research Center specializing in medicine, pathology, and human papillomavirus vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	1.2K
2	Cell Biology	5	5	558
3	Natural Sciences	4	4	420
4	Public Health	2	2	164
5	Epidemiology	1	1	85

Tomas Kahn

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations L. C. Ho, S Y Chan, Robert D. Burk, Journal of Virology Virus EpidemiologyHpv-16 GenomesGeneticsViral EvolutionPhylogenetics	1993	314
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Thomas Andl, Tomas Kahn, Andreas Pfuhl, PubMed PathologyTumor BiologyCarcinomaCancer-associated VirusPrb-defective Tonsillar Tumors	1998	283
Molecular cloning and characterization of the dna of a new human papillomavirus (hpv 30) from a laryngeal carcinoma Tomas Kahn, Elisabeth Schwarz, Harald zur Hausen International Journal of Cancer	1986	142
p16<sup>INK4a</sup> overexpression predicts translational active human papillomavirus infection in tonsillar cancer Markus Hoffmann, A.S. Ihloff, Tibor Görögh, International Journal of Cancer ImmunologyPathologyTumor BiologyCancer-associated VirusTranslational Biology	2010	125
Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients Markus Hoffmann, Tibor Görögh, Stefan Gottschlich, Cancer Letters Neck CancerCervical CancerHuman Papillomavirus VaccinesPathologyVirology	2005	94
HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer – How valid is p16INK4A as surrogate marker? Markus Hoffmann, Silke Tribius, Elgar Susanne Quabius, Cancer Letters Human Papillomavirus VaccinesMedicineP16ink4a ImmunohistochemistryPathologyCancer Diagnosis	2012	88
Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina Gustavo José Leirós, Silvia Galliano, Mario Eduardo Sember, BMC Urology	2005	85
Prevalence of human papillomavirus in cervical cancer: A multicenter study in China Keith W.K. Lo, Y. F. Wong, May K.M. Chan, International Journal of Cancer Epidemiology Of CancerGynecologyPathologyCytopathologyCarcinoma	2002	85
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma Klaus Zumbach, Markus Hoffmann, Tomas Kahn, International Journal of Cancer Viral DiagnosticsImmunologyPathologyHpv16 AntibodiesImmunotherapy	2000	79
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180 Simone Reuter, Hajo Delius, Tomas Kahn, Journal of Virology Molecular BiologyPathologyCancer-associated VirusHuman Papillomavirus VaccinesMolecular Pathology	1991	50

Page 1